CoraLite® Plus 488-conjugated DAPK1 Monoclonal antibody

DAPK1 Monoclonal Antibody for IF

Host / Isotype

Mouse / IgG1

Reactivity

Human, Mouse, Rat

Applications

IF

Conjugate

CoraLite® Plus 488 Fluorescent Dye

CloneNo.

1E2F9

Cat no : CL488-67815

Synonyms

DAP kinase 1, DAPK, DAPK1, DKFZp781I035



Tested Applications

Positive IF detected inhuman breast cancer tissue

Recommended dilution

ApplicationDilution
Immunofluorescence (IF)IF : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

CL488-67815 targets DAPK1 in IF applications and shows reactivity with Human, Mouse, Rat samples.

Tested Reactivity Human, Mouse, Rat
Host / Isotype Mouse / IgG1
Class Monoclonal
Type Antibody
Immunogen DAPK1 fusion protein Ag29838
Full Name death-associated protein kinase 1
Calculated Molecular Weight 1430 aa, 160 kDa
Observed Molecular Weight160 kDa
GenBank Accession NumberBC113660
Gene Symbol DAPK1
Gene ID (NCBI) 1612
RRIDAB_2919555
Conjugate CoraLite® Plus 488 Fluorescent Dye
Excitation/Emission Maxima Wavelengths493 nm / 522 nm
Form Liquid
Purification MethodProtein G purification
Storage Buffer PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3.
Storage ConditionsStore at -20°C. Avoid exposure to light. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

DAPK1(Death-associated protein kinase 1) is a stress-activated tumor suppressor protein that plays a role in both proapoptotic or antiapoptotic signal transduction pathways. Loss of DAPK1 expression is associated with a selective advantage fortumor cells to resist apoptotic stimuli, allowing them to separate from the original tumor; from this point of view, DAPK1 could be considered a tumor metastases inhibitor gene(PMID:17319784).

Protocols

Product Specific Protocols
IF protocol for CL Plus 488 DAPK1 antibody CL488-67815Download protocol
Standard Protocols
Click here to view our Standard Protocols